Galapagos is now Lakefront Biotherapeutics.
Joined May 2011
- Tweets 1,197
- Following 447
- Followers 3,415
- Likes 272
799 Photos and videos
Press Release | Lakefront Appoints Eric Hedrick, MD as Chief Medical Officer.
Read more:
lakefrontbio.com/press-relea…
150
We are thrilled to welcome the talented and accomplished Ouro Medicines team to Lakefront.
This collaboration brings a clinically meaningful, high‑potential asset and three exciting, early-stage programs into our portfolio.
We are excited to get to work together.
1
199
Press Release | Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Galapagos will host a conference call and webcast presentation May 7, 2026, at 14:00 CET / 8:00 am ET.
Read more in our press release: glpg.com/press-releases/gala…
278
We're pleased to share that today our shareholders approved our proposal to change our name to Lakefront Biotherapeutics, effective May 8th.
Read more: glpg.com/press-releases/gala…
2
293
Press Release | Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases.
Read more in our press release: bit.ly/4s33hyo
2
333
Press Release | Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings
Read more: glpg.com/press-releases/gala…
187
Press release | Galapagos Appoints Tania Philipp as Chief Human Resources Officer.
A seasoned life sciences executive, Ms. Philipp joins Galapagos with a strong track record in change management.
Read more:
glpg.com/press-releases/gala…
1
1
248
📢 Watch the replay of our full year 2025 earnings conference call for investors and analysts.
For details, visit our Webcasts section:
glpg.com/webcasts-events/
1
175
Press release | Galapagos Reports Full Year 2025 Results and Provides Fourth Quarter Business Update
Read more: glpg.com/press-releases/gala…
2
3
661
Press release | Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors.
Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board.
Read more: glpg.com/press-releases/gala…
1
2
294
📢 Galapagos to Host Conference Call to Discuss Full Year 2025 Financial Results and Provide Fourth Quarter Business Update on February 23, 2026.
For details, visit our Webcasts section:
glpg.com/webcasts-events/
1
1
244
23 Dec 2025
As 2025 comes to a close, we want to thank our colleagues, our partners, the scientific communities and the patients who participate in our clinical studies for the collaboration, dedication, and shared purpose that define our work.
Happy holidays!
1
234
18 Dec 2025
Press Release | Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor in Dermatomyositis and Systemic Lupus Erythematosus.
Read more: glpg.com/press-releases/gala…
202
7 Nov 2025
We are pleased to announce the formation of Galapagos’ Cross-Disciplinary Strategic Advisory Board.
Our new advisors — Dr. Scott Brun, Dr. Rob Lenz, Elaine Sorg, and Dr. Nancy Valente — bring deep experience across scientific innovation, development, and commercialization.
263
6 Nov 2025
📢 Watch the replay of our third quarter 2025 earnings conference call for investors and analysts.
For details, visit our Webcasts section:
glpg.com/webcasts-events/
1
2
383
5 Nov 2025
Press release | Galapagos Reports First Nine Months of 2025 Financial Results and Provides Business Update
Read more: glpg.com/press-releases/gala…
1
232
3 Nov 2025
Press release | Galapagos to Present New Data from Cell Therapy Program at #ASH2025.
Read more: glpg.com/press-releases/gala…
1
394
30 Oct 2025
Press Release ǀ Galapagos Welcomes Dr. Neil Johnston and Devang Bhuva to its Board of Directors.
New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board.
Read more: glpg.com/press-releases/gala…
1
3
267
29 Oct 2025
📢 Galapagos to Host Conference Call to Discuss First Nine Months of 2025 Financial Results and Business Update on November 6, 2025.
For details, visit our Webcasts section:
glpg.com/webcasts-events/
219
23 Oct 2025
Press Release ǀ Galapagos to present new data on its TYK2 inhibitor at #ACR25.
At clinically relevant exposures, the drug candidate showed selective inhibition of TYK2-mediated signaling, while sparing the IL-10 anti-inflammatory pathway.
Read more: glpg.com/press-releases/gala…
2
361